You have 9 free searches left this month | for more free features.

Previously treated Chronic Lymphocytic Leukemia (CLL)

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Nagoya-shi, Aichi, Japan
  • +19 more
Jan 25, 2023

Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

Not yet recruiting
  • Autoimmune Hemolytic Anemia
  • +3 more
  • Ibrutinib 420 mg
  • (no location specified)
Jan 12, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Phoenix, Arizona
  • +116 more
Jun 27, 2022

Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Observation
  • (no location specified)
Oct 12, 2023

Hepatitis, Safety and Tolerability Trial run by the NHLBI (HEPLISAV-B)

Completed
  • Hepatitis
  • Safety and Tolerability
  • HEPLISAV-B
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 13, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

MEOI and HRQoL in CLL Patients Treated With BTKis

Recruiting
  • Chronic Lymphocytic Leukemia
    • Fountain Valley, California
    • +15 more
    Jan 16, 2023

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 9, 2022

    Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Whittier, California
      Innovative Clinical Research Institute
    Aug 8, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 2, 2022

    B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Manhasset, New York
        Feinstein Institute for Medical research
      Jul 6, 2022

      Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Milano, MI, Italy
        Ospedale San Raffaele
      Apr 2, 2022

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      Venetoclax Treatment in Chronic Lymphocytic Leukemia Routine

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
        • Be'er Sheva, HaDarom, Israel
        • +12 more
        Sep 9, 2022

        SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Biospecimen Collection
        • Electronic Health Record Review
        • Duarte, California
        • +10 more
        Jan 12, 2023

        Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

        Completed
        • CLL
          • Tampere, Finland
            Tampere university Hospital
          Feb 22, 2022

          Obinutuzumab in Follicular Lymphoma or Previously Untreated

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Follicular Lymphoma
          • obinutuzumab
          • Busan, Korea, Republic of
          • +16 more
          Jul 1, 2022

          Chronic Lymphocytic Leukemia Trial in Spain (Ibrutinib 140 MG Oral Capsule [Imbruvica])

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
          • Ibrutinib 140 MG Oral Capsule [Imbruvica]
          • Palma De Mallorca, Illes Balears, Spain
          • +19 more
          Sep 15, 2022

          Chronic Lymphocytic Leukemia Trial in Israel, United States (Ublituximab, Ibrutinib)

          Completed
          • Chronic Lymphocytic Leukemia
          • Huntsville, Alabama
          • +87 more
          Apr 25, 2022

          Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)

          Completed
          • Chronic Lymphocytic Leukemia
          • BNC105P
          • Ibrutinib
          • Lebanon, New Hampshire
            Dartmouth-Hitchcock Medical Center
          Jan 3, 2023

          Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
          • +5 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 12, 2022

          Oral Venetoclax Tablets in Combination With Intravenous

          Terminated
          • Chronic Lymphocytic Leukemia (CLL)
            • Moscow, Moskva, Russian Federation
            • +3 more
            Nov 18, 2021

            Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)

            Recruiting
            • Chronic Lymphocytic Leukemia
            • [U-13C]glucose
            • [13C5]glutamine
            • Madison, Wisconsin
              University of Wisconsin
            Jun 15, 2022

            Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)

            Active, not recruiting
            • Chronic Lymphocytic Leukemia
            • Leukemia
            • Coral Gables, Florida
            • +8 more
            Sep 28, 2022